What is the association between depression and Alzheimer’s disease?

References

• Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry20(4), 380–385 (2007).
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am. J. Psychiatry162(9), 1588–1601 (2005).
   PubMed Web of Science ®Google Scholar
• Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am. J. Med.94(5A), 19S–22S (1993).
   Google Scholar
• Reynolds CF 3rd, Kupfer DJ. Depression and aging: a look to the future. Psychiatr. Serv.50(9), 1167–1172 (1999).
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer. Dis. Assoc. Disord.13(Suppl.) 3, S115–S123 (1999).
   PubMed Web of Science ®Google Scholar
• Korczyn AD. Mixed dementia – the most common cause of dementia. Ann. NY Acad. Sci.977, 129–134 (2002).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer’s disease. A practical update for the clinician. Dement. Geriatr. Cogn. Disord.17(1–2), 55–64 (2004).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Olin J. Depression in Alzheimer’s disease: overview and treatment. Biol. Psychiatry52(3), 243–252 (2002).
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am. J. Psychiatry157(5), 708–714 (2000).
   PubMed Web of Science ®Google Scholar
• Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am. J. Geriatr. Psychiatry10(2), 129–141 (2002).
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Zubenko WN, McPherson S et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease. Am. J. Psychiatry160(5), 857–866 (2003).
   PubMed Web of Science ®Google Scholar
• Payne JL, Sheppard JM, Steinberg M et al. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int. J. Geriatr. Psychiatry17(3), 247–253 (2002).
   PubMed Web of Science ®Google Scholar
• Ballard C, Bannister C, Solis M, Oyebode F, Wilcock G. The prevalence, associations and symptoms of depression amongst dementia sufferers. J. Affect. Disord.36(3–4), 135–144 (1996).
   PubMed Web of Science ®Google Scholar
• Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J. Affect. Disord.59(2), 97–106 (2000).
   PubMed Web of Science ®Google Scholar
• Park JH, Lee SB, Lee TJ et al. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer’s disease. Dement. Geriatr. Cogn. Disord.23(2), 67–73 (2007).
   PubMed Web of Science ®Google Scholar
• Simpson S, Allen H, Tomenson B, Burns A. Neurological correlates of depressive symptoms in Alzheimer’s disease and vascular dementia. J. Affect. Disord.53(2), 129–136 (1999).
   PubMed Web of Science ®Google Scholar
• Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am. J. Psychiatry150(12), 1806–1812 (1993).
   PubMed Web of Science ®Google Scholar
• Ballard CG, Cassidy G, Bannister C, Mohan RN. Prevalence, symptom profile, and aetiology of depression in dementia sufferers. J. Affect. Disord.29(1), 1–6 (1993).
   PubMed Web of Science ®Google Scholar
• Fischer P, Simanyi M, Danielczyk W. Depression in dementia of the Alzheimer type and in multi-infarct dementia. Am. J. Psychiatry147(11), 1484–1487 (1990).
   PubMed Web of Science ®Google Scholar
• Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic. A three-year prospective study. Arch. Neurol.42(9), 894–896 (1985).
   PubMedGoogle Scholar
• Cummings JL. Depression and Parkinson’s disease: a review. Am. J. Psychiatry149(4), 443–454 (1992).
   PubMed Web of Science ®Google Scholar
• Rickards H. Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke. J. Neurol. Neurosurg. Psychiatry76(Suppl. 1), I48–I52 (2005).
   PubMedGoogle Scholar
• Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology70(13), 1017–1022 (2008).
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Sabe L, Vazquez S et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease. Stroke27(3), 408–414 (1996).
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology51(6), 1546–1554 (1998).
   PubMed Web of Science ®Google Scholar
• Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease? J. Neurol. Neurosurg. Psychiatry69(2), 178–186 (2000).
   PubMed Web of Science ®Google Scholar
• Salmon E, Perani D, Collette F et al. A comparison of unawareness in frontotemporal dementia and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry79(2), 176–179 (2008).
   PubMed Web of Science ®Google Scholar
• Forsell Y, Jorm AF, Fratiglioni L, Grut M, Winblad B. Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia. Am. J. Psychiatry150(8), 1199–1202 (1993).
   PubMed Web of Science ®Google Scholar
• Payne JL, Lyketsos CG, Steele C et al. Relationship of cognitive and functional impairment to depressive features in Alzheimer’s disease and other dementias. J. Neuropsychiatry Clin. Neurosci.10(4), 440–447 (1998).
   PubMed Web of Science ®Google Scholar
• Brodaty H, Luscombe G. Depression in persons with dementia. Int. Psychogeriatr.8(4), 609–622 (1996).
   PubMedGoogle Scholar
• Devanand DP, Jacobs DM, Tang MX et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch. Gen. Psychiatry54(3), 257–263 (1997).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Salvador T, Lyketsos CG, Baker A et al. Quality of life in dementia patients in long-term care. Int. J. Geriatr. Psychiatry15(2), 181–189 (2000).
   PubMed Web of Science ®Google Scholar
• Kopetz S, Steele CD, Brandt J et al. Characteristics and outcomes of dementia residents in an assisted living facility. Int. J. Geriatr. Psychiatry15(7), 586–593 (2000).
   PubMed Web of Science ®Google Scholar
• Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am. J. Psychiatry147(8), 1049–1051 (1990).
   PubMed Web of Science ®Google Scholar
• Fahim S, van Duijn CM, Baker FM et al. A study of familial aggregation of depression, dementia and Parkinson’s disease. Eur. J. Epidemiol.14(3), 233–238 (1998).
   Google Scholar
• Lyketsos CG, Tune LE, Pearlson G, Steele C. Major depression in Alzheimer’s disease. An interaction between gender and family history. Psychosomatics37(4), 380–384 (1996).
   Google Scholar
• Harwood DG, Barker WW, Ownby RL, Duara R. Association between premorbid history of depression and current depression in Alzheimer’s disease. J. Geriatr. Psychiatry Neurol.12(2), 72–75 (1999).
   PubMed Web of Science ®Google Scholar
• Migliorelli R, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer’s disease. Am. J. Psychiatry152(1), 37–44 (1995).
   PubMed Web of Science ®Google Scholar
• Krishnan KR, Tupler LA, Ritchie JC Jr. et al. Apolipoprotein E-e 4 frequency in geriatric depression. Biol. Psychiatry40(1), 69–71 (1996).
   PubMed Web of Science ®Google Scholar
• Kim DH, Payne ME, Levy RM, MacFall JR, Steffens DC. APOE genotype and hippocampal volume change in geriatric depression. Biol. Psychiatry51(5), 426–429 (2002).
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Brandt J, Albert M et al. Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease. Neurology58(8), 1182–1188 (2002).
   PubMed Web of Science ®Google Scholar
• Salmon E, Perani D, Herholz K et al. Neural correlates of anosognosia for cognitive impairment in Alzheimer’s disease. Hum. Brain Mapp.27(7), 588–597 (2006).
   PubMed Web of Science ®Google Scholar
• Forstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R. Clinical and neuropathological correlates of depression in Alzheimer’s disease. Psychol. Med.22(4), 877–884 (1992).
   PubMed Web of Science ®Google Scholar
• Zubenko GS. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology6(2), 77–93 (1992).
   PubMed Web of Science ®Google Scholar
• Ritchie K, Lovestone S. The dementias. Lancet360(9347), 1759–1766 (2002).
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261(5123), 921–923 (1993).
   PubMed Web of Science ®Google Scholar
• Henderson AS, Easteal S, Jorm AF et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet346(8987), 1387–1390 (1995).
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer. Dis. Assoc. Disord.20(3 Suppl. 2), S69–S74 (2006).
   PubMed Web of Science ®Google Scholar
• Kokmen E. The EURODEM collaborative re-analysis of case-control studies of Alzheimer’s disease: implications for clinical research and practice. Int. J. Epidemiol.20(Suppl. 2), S65–S67 (1991).
   Google Scholar
• Speck CE, Kukull WA, Brenner DE et al. History of depression as a risk factor for Alzheimer’s disease. Epidemiology6(4), 366–369 (1995).
   PubMed Web of Science ®Google Scholar
• Tsolaki M, Fountoulakis K, Chantzi E, Kazis A. Risk factors for clinically diagnosed Alzheimer’s disease: a case–control study of a Greek population. Int. Psychogeriatr.9(3), 327–341 (1997).
   PubMedGoogle Scholar
• Broe GA, Henderson AS, Creasey H et al. A case-control study of Alzheimer’s disease in Australia. Neurology40(11), 1698–1707 (1990).
   PubMed Web of Science ®Google Scholar
• Zalsman G, Aizenberg D, Sigler M, Nahshony E, Karp L, Weizman A. Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression. J. Nerv. Ment. Dis.188(4), 242–243 (2000).
   PubMedGoogle Scholar
• Andersen K, Lolk A, Kragh-Sorensen P, Petersen NE, Green A. Depression and the risk of Alzheimer disease. Epidemiology16(2), 233–238 (2005).
   PubMed Web of Science ®Google Scholar
• Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol.156(5), 445–453 (2002).
   PubMed Web of Science ®Google Scholar
• Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex, and risk for Alzheimer’s disease. Ann. Neurol.57(3), 381–387 (2005).
   PubMed Web of Science ®Google Scholar
• Reid LM, Maclullich AM. Subjective memory complaints and cognitive impairment in older people. Dement. Geriatr. Cogn. Disord.22(5–6), 471–485 (2006).
   PubMed Web of Science ®Google Scholar
• Butters MA, Whyte EM, Nebes RD et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch. Gen. Psychiatry61(6), 587–595 (2004).
   PubMed Web of Science ®Google Scholar
• Nebes RD, Butters MA, Houck PR et al. Dual-task performance in depressed geriatric patients. Psychiatry Res.102(2), 139–151 (2001).
   PubMed Web of Science ®Google Scholar
• Christensen H, Griffiths K, Mackinnon A, Jacomb P. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J. Int. Neuropsychol. Soc.3(6), 631–651 (1997).
   PubMedGoogle Scholar
• Nebes RD, Pollock BG, Houck PR et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J. Psychiatr. Res.37(2), 99–108 (2003).
   PubMed Web of Science ®Google Scholar
• Backman L, Hill RD, Forsell Y. The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults. J. Abnorm. Psychol.105(1), 97–105 (1996).
   PubMed Web of Science ®Google Scholar
• Dufouil C, Fuhrer R, Dartigues JF, Alperovitch A. Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am. J. Epidemiol.144(7), 634–641 (1996).
   PubMed Web of Science ®Google Scholar
• Vinkers DJ, Gussekloo J, Stek ML, Westendorp RG, van der Mast RC. Temporal relation between depression and cognitive impairment in old age: prospective population based study. BMJ329(7471), 881 (2004).
   PubMed Web of Science ®Google Scholar
• Herrmann LL, Goodwin GM, Ebmeier KP. The cognitive neuropsychology of depression in the elderly. Psychol. Med.37(12), 1693–1702 (2007).
   PubMed Web of Science ®Google Scholar
• Ganguli M, Du Y, Dodge HH, Ratcliff GG, Chang CC. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch. Gen. Psychiatry63(2), 153–160 (2006).
   PubMed Web of Science ®Google Scholar
• Bassuk SS, Berkman LF, Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch. Gen. Psychiatry55(12), 1073–1081 (1998).
   PubMed Web of Science ®Google Scholar
• Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch. Gen. Psychiatry56(3), 261–266 (1999).
   PubMed Web of Science ®Google Scholar
• Ritchie K, Gilham C, Ledesert B, Touchon J, Kotzki PO. Depressive illness, depressive symptomatology and regional cerebral blood flow in elderly people with sub-clinical cognitive impairment. Age Ageing28(4), 385–391 (1999).
   Google Scholar
• Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch. Gen. Psychiatry56(5), 425–430 (1999).
   PubMed Web of Science ®Google Scholar
• Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust. NZ J. Psychiatry35(6), 776–781 (2001).
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with “reversible dementia”: a controlled study. Am. J. Psychiatry150(11), 1693–1699 (1993).
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol. Psychiatry34(3), 141–145 (1993).
   PubMed Web of Science ®Google Scholar
• Rubin EH, Veiel LL, Kinscherf DA, Morris JC, Storandt M. Clinically significant depressive symptoms and very mild to mild dementia of the Alzheimer type. Int. J. Geriatr. Psychiatry16(7), 694–701 (2001).
   PubMed Web of Science ®Google Scholar
• Mayberg HS. Frontal lobe dysfunction in secondary depression. J. Neuropsychiatry Clin. Neurosci.6(4), 428–442 (1994).
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Murphy CF, Gunning-Dixon FM et al. Microstructural white matter abnormalities and remission of geriatric depression. Am. J. Psychiatry165(2), 238–244 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor WD, MacFall JR, Payne ME et al. Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res.139(1), 1–7 (2005).
   Web of Science ®Google Scholar
• Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer’s disease: a quantitative study. Stroke31(9), 2182–2188 (2000).
   Web of Science ®Google Scholar
• Parnetti L. Pathophysiology of vascular dementia and white matter changes. Rev. Neurol. (Paris)155(9), 754–758 (1999).
   PubMed Web of Science ®Google Scholar
• Steffens DC, Potter GG, McQuoid DR et al. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. Am. J. Geriatr. Psychiatry15(10), 839–849 (2007).
   PubMed Web of Science ®Google Scholar
• Greenwald BS, Kramer-Ginsberg E, Bogerts B et al. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer‘s disease? Psychol. Med.27(2), 421–431 (1997).
   PubMedGoogle Scholar
• Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch. Neurol.47(2), 209–214 (1990).
   PubMedGoogle Scholar
• Chen Z, Skolnick P. Triple uptake inhibitors: therapeutic potential in depression and beyond. Expert Opin. Investig. Drugs16(9), 1365–1377 (2007).
   PubMed Web of Science ®Google Scholar
• Reinikainen KJ, Soininen H, Riekkinen PJ. Neurotransmitter changes in Alzheimer’s disease: implications to diagnostics and therapy. J. Neurosci. Res.27(4), 576–586 (1990).
   PubMedGoogle Scholar
• Devanand DP, Sano M, Tang MX et al. Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch. Gen. Psychiatry53(2), 175–182 (1996).
   PubMed Web of Science ®Google Scholar
• Geerlings MI, Schoevers RA, Beekman AT et al. Depression and risk of cognitive decline and Alzheimer’s disease. Results of two prospective community-based studies in The Netherlands. Br. J. Psychiatry176, 568–575 (2000).
   PubMed Web of Science ®Google Scholar
• Green RC, Cupples LA, Kurz A et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol.60(5), 753–759 (2003).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Barnes LL, Mendes de Leon CF et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology59(3), 364–370 (2002).
   PubMed Web of Science ®Google Scholar
• Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatry75(12), 1662–1666 (2004).
   PubMed Web of Science ®Google Scholar
• Van Duijn CM, Clayton DG, Chandra V et al. Interaction between genetic and environmental risk factors for Alzheimer’s disease: a reanalysis of case-control studies. EURODEM Risk Factors research group. Genet. Epidemiol.11(6), 539–551 (1994).
   PubMed Web of Science ®Google Scholar
• Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry63(5), 530–538 (2006).
   PubMed Web of Science ®Google Scholar
• Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology70(15), 1258–1264 (2008).
   PubMed Web of Science ®Google Scholar
• Kessing LV, Søndergård L, Forman JL, Andersen PK. Antidepressants and dementia. J. Affect. Disord.117(1–2), 24–29 (2009).
   PubMed Web of Science ®Google Scholar
• Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev.4(2), 141–194 (2005).
   PubMed Web of Science ®Google Scholar
• Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord.4(2), 117–128 (2002).
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol. Psychiatry48(8), 755–765 (2000).
   PubMed Web of Science ®Google Scholar
• Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke34(2), 335–337 (2003).
   PubMedGoogle Scholar
• Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. J. Gerontol. A Biol. Sci. Med. Sci.59(2), 178–183 (2004).
   PubMedGoogle Scholar
• Baldwin RC. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int. J. Geriatr. Psychiatry20(1), 1–11 (2005).
   Web of Science ®Google Scholar
• Parissis JT, Adamopoulos S, Rigas A et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am. J. Cardiol.94(10), 1326–1328 (2004).
   PubMed Web of Science ®Google Scholar
• Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology29(9), 1119–1128 (2004).
   PubMed Web of Science ®Google Scholar
• Lavretsky H, Ercoli L, Siddarth P, Bookheimer S, Miller K, Small G. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia. Am. J. Geriatr. Psychiatry11(6), 667–673 (2003).
   PubMed Web of Science ®Google Scholar
• Muller-Thomsen T, Arlt S, Ganzer S et al. Depression in Alzheimer’s disease might be associated with apolipoprotein E ε4 allele frequency in women but not in men. Dement. Geriatr. Cogn. Disord.14(2), 59–63 (2002).
   PubMed Web of Science ®Google Scholar
• Ramachandran G, Marder K, Tang M et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer’s disease. Neurology47(1), 256–259 (1996).
   Google Scholar
• Butters MA, Sweet RA, Mulsant BH et al. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression. Int. J. Geriatr. Psychiatry18(12), 1075–1081 (2003).
   Google Scholar
• Slifer MA, Martin ER, Gilbert JR, Haines JL, Pericak-Vance MA. Resolving the relationship between Apolipoprotein E and depression. Neurosci. Lett.455(2), 116–119 (2009).
   PubMed Web of Science ®Google Scholar
• Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC. A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for Alzheimer‘s disease. Biol. Psychiatry41(8), 851–856 (1997).
   PubMed Web of Science ®Google Scholar
• Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch. Neurol.58(12), 1985–1992 (2001).
   PubMed Web of Science ®Google Scholar
• Lee JS, Potter GG, Wagner HR, Welsh-Bohmer KA, Steffens DC. Persistent mild cognitive impairment in geriatric depression. Int. Psychogeriatr.19(1), 125–135 (2007).
   PubMed Web of Science ®Google Scholar
• Steffens DC, Otey E, Alexopoulos GS et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch. Gen. Psychiatry63(2), 130–138 (2006).
   PubMed Web of Science ®Google Scholar